Caxton Associates (New York)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-3,076
Closed -$219K – 472
2023
Q3
$219K Sell
3,076
-19,236
-86% -$1.44M 0.03% 348
2023
Q2
$1.72M Sell
22,312
-4,710
-17% -$365K 0.25% 84
2023
Q1
$2.03M Buy
27,022
+12,065
+81% +$897K 0.31% 50
2022
Q4
$1.18M Buy
14,957
+10,394
+228% +$779K 0.08% 93
2022
Q3
$321K Sell
4,563
-7,279
-61% -$571K 0.04% 313
2022
Q2
$949K Buy
+11,842
New +$926K 0.09% 138
2022
Q1
– Sell
-7,089
Closed -$605K – 540
2021
Q4
$605K Buy
+7,089
New +$554K 0.06% 226
2021
Q3
– Sell
-3,578
Closed -$291K – 465
2021
Q2
$291K Buy
+3,578
New +$293K 0.03% 317
2020
Q4
– Sell
-4,946
Closed -$382K – 165
2020
Q3
$382K Buy
+4,946
New +$377K 0.04% 153
2018
Q3
– Sell
-5,202
Closed -$337K – 421
2018
Q2
$337K Buy
+5,202
New +$340K 0.02% 300
2018
Q1
– Sell
-7,500
Closed -$566K – 342
2017
Q4
$566K Sell
7,500
-2,500
-25% -$183K 0.03% 282
2017
Q3
$729K Sell
10,000
-115,000
-92% -$8.29M 0.03% 234
2017
Q2
$9.27M Buy
125,000
+10,000
+9% +$742K 0.36% 78
2017
Q1
$8.42M Buy
+115,000
New +$8.05M 0.03% 59
2016
Q4
– Sell
-240,000
Closed -$17.8M – 219
2016
Q3
$17.8M Buy
+240,000
New +$17.7M 0.6% 30

Other funds holding CL

Caxton Associates (New York)'s CL Position: Q4 2023 in Review

Caxton Associates (New York) sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 3,076 shares — an estimated $219K sold.

Caxton Associates (New York) first reported a position in CL in Q3 2016 and held it in 15 quarters. The position peaked at $17.8M in Q3 2016. 1,742 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Caxton Associates (New York) reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,076 Colgate-Palmolive shares in Q4 2023, an estimated $219K.
  • Caxton Associates (New York) first reported a position in Colgate-Palmolive in Q3 2016 and held it in 15 quarters.
  • Caxton Associates (New York)'s Colgate-Palmolive position peaked at $17.8M in Q3 2016.
  • 1,742 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.